DOCSLIB.ORG

Inpsych Newsletter Summer 07

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Inpsych Newsletter Summer 07 InInPsPsVol Twoyy • Summerchch 2007 16 Researchers Receive NARSAD Young Investigator Awards Sixteen Columbia Psychiatry researchers have been Marianne Gorlyn, PhD, seeks to understand the stress selected by NARSAD: The Mental Health Research response in people who attempt suicide. Dr. Gorlyn Association to receive a 2007 Young Investigator will use violent video game play as a novel stress Award. NARSAD is the world's leading donor-supported induction paradigm to characterize changes in organization dedicated to funding research on cognitive, cardiovascular and biochemical functioning psychiatric disorders. Each of the scientists will that emerge under such provocation. receive $60,000 from NARSAD for the next two years to advance specific research projects: David Kimhy, PhD, plans to study arousal and paranoia in schizophrenia to learn whether arousal precedes paranoia or is the result of it. Working with paranoid schizophrenia patients and normal controls, Dr. Kimhy and his group have designed methods to closely follow daily functioning. Diane Alix Klein, MD, will test mifepristone as a possible treatment for anorexia nervosa, a disorder for which no single medication has proved effective. Dana Lizardi, PhD, is working on a method for improving treatment for suicide, a major danger for people with psychiatric illness. The goal of Dr. Seated, left to right: Rachel Marsh, Christina Mangurian, Lizardi’s project is to develop an intervention to Joanna Steinglass, Marianne Gorlyn enhance treatment engagement of suicidal patients. Standing, left to right: Andrew Gerber, Jeffrey Miller, Antonio Montavani, Jason Scalia, David Kimhy, Ardesheer Talati Christina V. Mangurian, MD, seeks to determine In This Issue whether behavioral therapy can reduce obesity in Andrew J. Gerber, MD, PhD, will study brain dysfunc- Hispanics patients taking antipsychotic medication. tion in panic disorder and how these brain changes 2 .....New Recruits The Hispanic population is at greatest risk of obesity respond to psychotherapy. Two novel imaging methods in the U.S. will be used to look at the brain while the subject is 3 .....Tick-Borne Diseases performing a task indicating when regions of the brain Antonio Mantovani, MD, PhD, will test repetitive tran- Research Center are more or less active. scranial magnetic stimulation (rTMS) in the treatment 4 .....NARSAD Names New President Gray Matters at Columbia 4 .....Kolb Legacy Gray Matters, a family foundation in New York and ness,” said Farah Moinian. “We believe that research on 5 .....Awards & Recognitions London led by Farah Moinian and her sister Shirin mental illness is truly the science of hope,” she added. Moinian, announced the creation of a $250,000 6 .....Grant News research fellowship at the Columbia University Medical Center Department of Psychiatry on May 2nd. The Gray 7 .....Clinical Services Matters fellowship will focus on the genetic underpin- nings of schizophrenia with the hope that expanded 8 .....Department Reading List research will lead to better treatment and ultimately a cure. The fellowship awardee to be announced in the spring of 2008 will benefit from the multi-disciplinary expertise and collaboration of the department’s Lieber Columbia Department Center for Schizophrenia Research. of Psychiatry “We are proud that our partnership with Columbia University’s Department of Psychiatry. Under the lead- From left: Farah Moinian, her mother Vajihe Soleymani, Dr. New York State ership of Dr Jeffery Lieberman, Gray Matters will fund Jeffrey Lieberman, Sylvia Nasar, author of A Beautiful Mind Psychiatric Institute a bright young researcher in the genetics of mental ill- and Shirin Moinian. NewNewRecruitsRecruits Naihua Duan Thomas (Tom) Smith Dr. Naihua Duan, formerly of Dr. Thomas Smith joined the Message from the UCLA Departments of department as Director of Psychotic Disorders Services Chairman and Director Psychiatry and Biostatistics, joined the department on May in April after six years as 1 as the Director of the Medical Director at the The Nobel Laureate Julius Axelrod once Columbia affiliate Hall-Brooke Division of Biostatistics. As a said that, “Ninety-nine percent of the Behavioral Health Services in Columbia alumnus (MA in Mathematical discoveries are made by 1% of the Westport, Connecticut. In this capacity, he will Statistics, 1975), he is excited to “come home scientists.” I would like to think that lead the newly opened Lieber Clinic for and make a contribution to his alma mater.” He a substantial proportion of that 1% Comprehensive Care of Schizophrenia on E. noted that Dr. Lieberman’s commitment to come from Columbia. We have stellar 60th street as well as the Schizophrenia developing biostatistics as a priority area in the Research Unit (SRU) and outpatient researchers and elite clinicians who are department was the deciding factor in his schizophrenia clinic at PI. leaders in their fields. We are fortunate decision to accept the offer to lead the to have an unrivaled wellspring of talent Biostatistics Division. Prior to moving to Hall-Brooke, Dr. Smith was in our trainees and junior faculty who Director of Continuing Care Services at the have the potential to advance our A “practicing biostatistician,” as he describes Weill-Cornell Campus of New York-Presbyterian knowledge base. However, to succeed himself, Dr. Duan's primary objective is to build Hospital. His career has focused on recovery and rehabilitation and the impact of cognitive they must have adequate support at a strong division that excels in collaboration the critical early stages of their career. deficits on functional capacity and learning and consultation. He encourages researchers to abilities of people with schizophrenia. That embrace the “cradle through maturity model,” The traditional sources of support that work now will help the Lieber Clinic realize one that is, collaborating with biostatisticians early we have relied on for the career devel- of its key aims: assisting patients in enhancing on in the research process, beginning with opment of trainees and junior faculty their recovery through rehabilitation and research design and conceptualization. Based independent living skills. The Clinic, unlike are contracting severely. The current on his previous experience, this model can help others serving individuals with schizophrenia, economy has markedly constrained the improve the quality and efficiency of research will focus more on addressing the cognitive NIH budget and changes in mental studies and avoid potential problems. deficits that characterize the disorder. This is health care financing over the past two the most frustrating aspect of treatment and decades have placed great pressure on He is keenly interested in recruiting high-caliber recovery, said Dr. Smith: “The most recent clinicians, making it more difficult to biostatisticians who excel both in collaboration schizophrenia research shows that it is the develop skilled psychiatrists in the and in methodological research. As he prepares cognitive deficits that limit functioning in much needed subspecialty areas to recruit several new faculty members in the society, not the paranoia or hallucinations.” including consultation-liaison, emer- coming years, Dr. Duan welcomes the input At the Psychiatric Institute, he will reorganize gency, geriatrics and child psychiatry. of investigators to help him prioritize the the psychosis clinical services, which include sub-specialty areas of biostatistics needed for To supplement the traditional sources the SRU and its companion outpatient clinic. the department. of support for career development for The SRU doubled in size in July, greatly expanding its capacity to support research on junior faculty, we are pursuing fundrais- Dr. Duan is a graduate of Columbia University, the biology and treatment of schizophrenia. ing activities and private philanthropy. where he earned is MA in Mathematical The outpatient clinic at PI will be expanded Some funds will support aspiring Statistics, and of Stanford University, where he to support studies of the effectiveness of researchers in their training to establish earned his PhD in Statistics in 1979. His work new antipsychotic medications as well as themselves as independent investigators has spanned a broad range that includes health pharmacologic agents developed to enhance and sustain pilot studies of new and services research, clinical trials, HIV prevention cognition. Dr. Smith also plans to continue his innovative projects. Other funding will research and environmental health. His expertise prior research on recovery from psychosis. help trainees who want to pursue spe- has, in the past, contributed to work carried out cialized clinical training for careers in A native of Michigan, Dr. Smith attended by a number of our faculty including Drs. Anke Wayne State University School of Medicine in hospital-based clinical care and teach- Ehrhardt and Hector Bird. Detroit and completed his residency at the ing. Information about funding opportu- University of Chicago Medical Center. During nities at Columbia Psychiatry are avail- his tenure at Cornell he held a number of able at www.ColumbiaPsychiatry.org leadership positions and developed an externally and from our Office of External funded clinical research service for psychotic Relations Director Laurie Flynn, disorders at the Westchester Division of New (212) 543-5799. York-Presbyterian. Dr. Smith has published extensively on recovery from psychosis and is a recipient of a National Institute of
Load more

Recommended publications
  • Drug Use Sequencing and Kandel's Gateway Hypothesis John Reid Clemson University, [email protected]
    Clemson University TigerPrints All Theses Theses 8-2008 Drug Use Sequencing and Kandel's Gateway Hypothesis John Reid Clemson University, [email protected] Follow this and additional works at: https://tigerprints.clemson.edu/all_theses Part of the Sociology Commons Recommended Citation Reid, John, "Drug Use Sequencing and Kandel's Gateway Hypothesis" (2008). All Theses. 447. https://tigerprints.clemson.edu/all_theses/447 This Thesis is brought to you for free and open access by the Theses at TigerPrints. It has been accepted for inclusion in All Theses by an authorized administrator of TigerPrints. For more information, please contact [email protected]. DRUG USE SEQUENCING AND KANDEL'S GATEWAY HYPOTHESIS A Thesis Presented to the Graduate School of Clemson University In Partial Fulfillment of the Requirements for the Degree Master of Science Applied Sociology by John Matthew Reid August 2008 Accepted by: Dr. Brenda Vander Mey, Committee Chair Dr. Douglas Kinly Sturkie Dr. Margaret Tina Britz i ABSTRACT This thesis tests the hypothesis by Kandel (1975) that there is a specific sequence of drug use that users follow. Using the same scalogram analysis technique utilized by Kandel in her original Gateway Hypothesis study, a distinct sequence of use was discovered. This thesis is based on the National Survey on Drug Use and Health (2005). This study confirmed Kandel’s earlier findings in that this study determined that there is a sequence of drug use. The current study also confirms Kandel’s position that licit drugs precede the use of illicit drugs. This study’s findings differ from those of Kandel, however, in that tobacco and not alcohol was found to be the first drug of experimentation.
    [Show full text]
  • A Molecular Basis for Nicotine As a Gateway Drug
    The new england journal of medicine special article shattuck lecture A Molecular Basis for Nicotine as a Gateway Drug Eric R. Kandel, M.D., and Denise B. Kandel, Ph.D. From the Howard Hughes Medical Insti- n the historic occasion of the 122nd Shattuck Lecture and tute (E.R.K.), Kavli Institute for Brain Sci- the 200th anniversary of the New England Journal of Medicine, we chose to ad- ence (E.R.K.), and the Departments of Neuroscience (E.R.K.) and Psychiatry Odress a topic that is at once scientific and personally historic. In recent (E.R.K., D.B.K.), College of Physicians debates over legalizing marijuana, from all-out acceptance in Colorado to narrow and Surgeons, and Mailman School of decriminalization in Maryland, the scientific question of the role of marijuana as a Public Health (D.B.K.), Columbia Univer- sity, and the New York State Psychiatric gateway drug (i.e., a drug that lowers the threshold for addiction to other agents) Institute (D.B.K.) — all in New York. Ad- has loomed large. Both opponents and proponents of legalization have distorted dress reprint requests to Dr. E. Kandel at what science does and does not tell us — and both sides have overlooked the im- the Department of Neuroscience, Col- lege of Physicians and Surgeons, Colum- portance of nicotine as a gateway drug. bia University, 1051 Riverside Dr., Unit Epidemiologic studies have shown that nicotine use is a gateway to the use of 87, New York, NY 10032, or at erk5@ marijuana and cocaine in human populations.
    [Show full text]
  • 2016 and Over 4,000 Research Scientists, 168 Scientific Leaders and 60,000 Was Our Leader and Guiding Light, Providing Inspiration and Moti- Pression
    INVEST IN MENTAL HEALTH ANNUAL REPORT 2 0 1 6 Dear Brain & Behavior Research Foundation Supporters: From mental illness to mental health–30 years of achievements by tremendous impact on psychiatric research and treatment. Connie problems improves symptoms of some patients with refractory de- The Foundation is proud of our accomplishments in 2016 and over 4,000 research scientists, 168 scientific leaders and 60,000 was our leader and guiding light, providing inspiration and moti- pression. In a study of patients with treatment-resistant depression, we are excited to focus on the promising path of discovery. With donors. We are proud to present you with our 2016 annual report vation to all who ever had the honor and privilege of knowing and about two thirds had metabolic deficiencies that affect the brain’s your sustained commitment, we will accelerate the funding of our and invite you to invest in mental health. working with her. She will be dearly missed by us all. But her legacy ability to produce neurotransmitters. Dr. Pan’s research found Grants and continue to lead the field with breakthroughs that continues with each new scientist which we support and each new that patients’ depression symptoms declined significantly when improve the lives of those living with mental illness. Thank you for Since 1987, the Brain & Behavior Research Foundation has invest- discovery which improves people’s lives. their metabolic problems were treated. Some of the patients even continuing the journey with us. ed in the future. We support the innovative brain and behavior reached remission. The most common of the deficiencies observed research today which will lead to new treatments and eventual While we are proud of our accomplishments, there is still much in the participants was in levels of cerebral folate, which is treat- Sincerely, cures in the future.
    [Show full text]
  • Substance Abuse by Adolescents in 1977 with 499 French Adolescents
    In a country like Israel, which is deeply committed to the main sources of infection, among them active foci achievement of an expanded immunization program, the still present in the neighboring territories. effort to reach this objective should be weighed within the national program aimed at elimination of the diseases References .................................. controlled by mass immunization. Analysis of present achievements clearly shows that measles, together with 1. Swartz, T. A., and Klingberg, W.: Routine measles immu- poliomyelitis and rubella, deserves to be included among nization in Israel: A three-year clinical and serologic follow- up. In International conference on application of vaccines the first priorities of a program whose objective is elim- against viral, rickettsial, and bacterial diseases of man, ination of clinical disease. Washington, D.C., 14-18 December 1970. Pan American Health Organization, Washington, D.C., 1971, pp. Conclusions 265-268. 2. Centers for Disease Control: Measles Surveillance Report No. 11, 1977-1981. Atlanta, Ga., September 1982. A 17-year-old immunization program has created the 3. Health and Welfare Canada: Measles in Canada. Canada basis for elimination of measles in Israel, provided that Diseases Weekly Report 9-25: 29-101 (1983). (a) the control policy is adapted to the seroepidemiology 4. World Health Organization: Measles surveillance. Weekly of the infection, and (b) a concentrated logistic effort is Epidemiol Record 58: 85-86 (1983). mounted in the period preceding the next expected epi- 5. Hopkins, D. R., Hinman, A. R., Kaplan, J. E, and Lane, J. M.: The case for global measles eradication. Lancet 1: demic. Under this effort: 1936-1938, June 19, 1982.
    [Show full text]
  • DOCUMENT RESUME ED 222 832 CG 016 300 AUTHOR Lettieri, Dan
    DOCUMENT RESUME ED 222 832 CG 016 300 AUTHOR Lettieri, Dan J., Ed.; Ludford, Jacqueline P., Ed. TITLE Drug Abuse and the American Adolescent. NIDA Research Monograph 38. A RAUS Review Report. INSTITUTION National Inst. on Drug Abuse (DHHS), Rockville, Md. Div. of Research. REPORT NO DHHS-ADM-81-1166 PUB DATE 8 Sep 80 NOTE 140p.; Papers presented at the Research Analysis and Utilization System (RAUS) Review Conference on Drug Abuse and the American Adolescent (Rockville, MD, September 8, 1980). AVAILABLE FROMSuperintendent of Documents, U.S. Government Printing Office, Washington, DC 20402. PUB TYPE Collected Works - Conference Proceedings (021) Reference Materials - Bibliographies (131) Reports Research/Technical (143) EDRS PRICE MF01/PC06 Plus Postage. DESCRIPTCRS *Adolescents; Biomedicine; Cohort Analysis; *Delinquent Behavior; Drinking; *Drug Abuse; Individual Differences; Literature Reviews; Longitudinal Studies; *Peer Influence; Personality Traits; *Predictor Variables; Secondary Education; *Youth Problems IDENTIFIERS *Epidemiology ABSTRACT This report reviews five studiei-dealing with drug abuse and adolescence and presents an overview of the social changes which have contributed to the increased use of marijuana and other illicit drugs. The importance of the longitudinal study as a research tool is emphasized in describing the research projects that dealwith the epidemiology of drug use, personality and sociodemographic factors, peer influence, the relationship between delinquency and drug use, and its biomedical consequences. The report closes with an executive summary, discussion, and suggestions for further research. An annotated list of NIDA (National Institute of DrugAbuse) research monographs is included. (JAC) *********************************************************************** Reproductions supplied by EDRS are the best that can be made from the original document. *********************************************************************** Drug Abuse and the American Adolescent Editors: Dan J.
    [Show full text]
  • Is Cannabis a Gateway Drug? Key Findings and Literature Review
    U.S. Department of Justice Office of Justice Programs National Institute of Justice National Institute of Justice Is Cannabis a Gateway Drug? Key Findings and Literature Review Wm. Nel, MSc, Researcher Judy Wang, PhD, Researcher November 2018 A Report Prepared by the Federal Research Division, Library of Congress, Under an Interagency Agreement with the Office of the Director, National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. NCJ 252950 U.S. Department of Justice Office of Justice Programs 810 Seventh St. N.W. Washington, DC 20531 David B. Muhlhausen, Ph.D. Director, National Institute of Justice This and other publications and products of the National Institute of Justice can be found at: National Institute of Justice Strengthen Science • Advance Justice nij.ojp.gov Office of Justice Programs Building Solutions • Supporting Communities • Advancing Justice O J P.gov The National Institute of Justice is the research, development, and evaluation agency of the U.S. Department of Justice. NIJ’s mission is to advance scientific research, development, and evaluation to enhance the administration of justice and public safety. The National Institute of Justice is a component of the Office of Justice Programs, which also includes the Bureau of Justice Assistance; the Bureau of Justice Statistics; the Office for Victims of Crime; the Office of Juvenile Justice and Delinquency Prevention; and the Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering, and Tracking. Opinions or conclusions expressed in this paper are those of the authors and do not necessarily reflect the official position or policies of the U.S. Department of Justice.
    [Show full text]
  • 17Th European Society for Biomedical Research on Alcoholism Congress 21-24 September 2019, Lille – Invited Talks and Symposia Abstracts
    Directeur de la rédaction Pr François Paille Rédacteur en chef Pr Amine Benyamina Rédacteurs associés Dr Philippe Batel Dr Ivan Berlin Dr Laurent Karila Pr Michel Lejoyeux Pr Mickaël Naassila Rédactrice Sciences humaines Pr Myriam Tsikounas Rédactrice Sciences psychologiques Pr Isabelle Varescon-Pousson Comité de rédaction Pr Georges Brousse Pr Olivier Cottencin Dr Michel Craplet Pr Jean-Bernard Daeppen Dr Jean-Michel Delile Pr Maurice Dematteis Dr Claudine Gillet th Dr Geneviève Lafaye 17 European Society for Biomedical Research Pr Michel Reynaud Dr Alain Rigaud Dr Marc Valleur on Alcoholism Congress Directeur de la publication Pr Mickael Naassila 21-24 September 2019, Lille Comité scientifique Pr Jean Adès Pr Thomas F. Babor Pr Jean-Louis Balmès Pr Maurice Bazot Dr Mats Berglund Pr Jacques Besson Pr Jean-Pierre Blayac Pr Jonathan D. Chick Mme Marie Choquet Pr Philippe de Witte Pr Michel Escande Pr Claude Got Dr Antoni Gual Pr Momar Gueye Pr Roger Henrion Pr Denise Kandel Pr Michel Le Moal Pr Karl Mann Mme Véronique Nahoum-Grappe Dr José Maria Neves Cardoso Pr Philippe-Jean Parquet Pr Jean-Louis Pedinielli Pr Falvio Poldrugo Pr Bernard Roques Pr John A. Talbott Pr Jean-Luc Vénisse Pr Lars von Knorring Pr Jacques Weill Pr Jean-Jacques Yvorel ISSN 2554-4853 Trimestriel Société Française PRINCEPS Éditions SEPTEMBRE-DÉCEMBRE 2019 - Tome 41, n° 3-4 d’Alcoologie !BSTRACTS CONGRÈS Pr Mickael Naassila* * President 17th ESBRA Meeting 17th European Society for Biomedical Research on Alcoholism congress 21-24 September 2019, Lille – Invited talks and Symposia abstracts Invited talks forward, such as combining training with neurostimulation.
    [Show full text]
  • Cocaine Use in America: Epidemiologic and Clinical Perspectives
    DOCUMENT RESUME ED 268 463 CG 019 022 AUTHOR Kozel, Nicholas J., Ed.; Adams, Edgar H., Ed. TITLE Cocaine Use in America: Epidemiologic and Clinical Perspectives. National Institute on Drug Abuse (NIDA) Research Monograph Series 61. INSTITUTION National Inst. on Drug Abuse (DHHS/PHS), Rockville, Md. REPORT NO DHHS-ADM-85-1414 PUB DATE 85 NOTE 243p. AVAILABLE FROMSuperintendent of Documents, U.S. Government Printing Office, Washington, DC 20402. PUB TYPE Reports - Research/Technical (143) -- Collected Works General (020) EDRS PRICE MF01/PC10 Plus Postage. DESCRIPTORS *Adolescents; *Behavior Patterns; *Drug Abuse; *Illegal Drug Use; Individual Characteristics; *Trend Analysis; *Young Adults IDENTIFIERS *Cocaine ABSTRACT This monograph is based on papers presented at a technical review of patterns of cocaine use in the United States which was held in 1984. The foreword by Jerome H. Jaffe acknowledges that, over the past 10 years, cocaine has become a major public health threat in this country. Papers contained in this monograph include: (1) "Cocaine Use in America: Introduction and Overview" by Edgar H. Adams and Nicholas J. Kozel; (2) "Cocaine Use in the United States: In a Blizzard or Just Being Snowed?" by Richard R. Clayton; (3) "A Decade of Trends in Cocaine Use in the Household Population" by Herbert I. Abelson and Judith Droitcour Miller; (4) "Cocaine Use Among American Adolescents and Young Adults" by Patrick M. O'Malley, Lloyd D. Johnston, and Jerald G. Bachman; (5) "Cocaine Use in Young Adulthood: Patterns of Use and Psychosocial Correlates" by Denise B. Kandel, Debra Murphy, and Daniel Karus; (6) "Patterns and Consequences of Cocaine Use" by Dale D.
    [Show full text]
  • Preventing Adolescent Drug Abuse: Intervention Strategies, 47
    RESEARCH ANALYSIS and UTILIZATION SYSTEM Preventing Adolescent Drug Abuse: Intervention Strategies U. S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service • Alcohol, Drug Abuse, and Mental Health Administration Preventing Adolescent Drug Abuse Intervention Strategies Editors: Thomas J. Glynn, Ph.D. Carl G. Leukefeld, D.S.W. Jacqueline P. Ludford, M.S. National Institute on Drug Abuse NIDA Research Monograph 47 A RAUS Review Report DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse 5600 Fishers Lane Rockville, Maryland 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, D.C. 20402 NIDA Research Monographs are prepared by the research divtsrons of the National lnstitute on Drug Abuse and published by its Office of Science. The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. Its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph D. SIDNEY COHEN, M.D Temple University School of Medicine Los Angeles, California Philadelphia, Pennsylvania SYDNEY ARCHER, Ph.D. MARY L. JACOBSON Rensselaer Polytechnic lnstitute National Federation of Parents for Troy, New York Drug Free Youth Omaha, Nebraska RICHARD E. BELLEVILLE, Ph.D. NB Associates, Health Sciences Rockville, Maryland REESE T. JONES, M.D. KARST J. BESTEMAN Langley Porter Neuropsychiatric Institute Alcohol and Drug Problems Association San Francisco, California of North America Washington, D.C DENISE KANDEL, Ph.D.
    [Show full text]
  • NCI Cancer Prevention Fellowship Program
    DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE NATIONAL INSTITUTES OF HEALTH NATIONAL CANCER INSTITUTE 4TH JOINT MEETING OF THE BOARD OF SCIENTIFIC ADVISORS AND THE NATIONAL CANCER ADVISORY BOARD Summary of Meeting December 2, 2014 Building 31C, Conference Room 10 National Institutes of Health Bethesda, Maryland 4th Joint Meeting of the Board of Scientific Advisors and the National Cancer Advisory Board NATIONAL CANCER ADVISORY BOARD BETHESDA, MARYLAND Summary of Meeting December 2, 2014 The Board of Scientific Advisors (BSA) and the National Cancer Advisory Board (NCAB) convened for the 4th Joint Meeting on 2 December 2014, in Conference Room 10, C Wing, Building 31, National Institutes of Health (NIH), Bethesda, MD. The meeting was open to the public on Tuesday, 2 December 2014, from 8:30 a.m. to 12:30 p.m. and 1:15 p.m. to 4:55 p.m., and closed to the public from 12:30 p.m. to 1:15 p.m. The BSA Chair, Todd R. Golub, Chief Scientific Officer, The Broad Institute of Harvard University and Massachusetts Institute of Technology, and the NCAB Chair, Tyler Jacks, Director, Koch Institute for Integrative Cancer Research, David H. Koch Professor of Biology, Massachusetts Institute of Technology, presided during the open session. Dr. Jacks presided during the closed session. BSA Members NCAB Members Dr. Todd R. Golub (Chair) Dr. Tyler E. Jacks (Chair) Dr. Francis Ali-Osman (absent) Dr. David C. Christiani (absent) Dr. Kenneth C. Anderson Dr. Marcia R. Cruz-Correa (absent) Dr. Dafna Bar-Sagi Dr. Kevin J. Cullen Dr. Ethan M.
    [Show full text]
  • Table of Contents SPR
    Table of Contents SPR ABOUT THE ANNUAL MEETING and SPR Acknowledgements ......................................................................................................... 3 Welcome from the President ............................................................................................ 7 Board of Directors .......................................................................................................... 9 Welcome from the Program Planning Committee Chair ................................................... 13 Program Committees ...................................................................................................... 14 About SPR ..................................................................................................................... 20 SPR Awards .................................................................................................................... 21 Celebrating 10 Years of Prevention Science ........................................................................ 23 MEETING PROGRAM AND ACTIVITIES Preconference Workshops ................................................................................................. 25 Diversity Network Committee and DNC Meeting Activities .............................................. 35 ECPN and ECPN Meeting Activities ................................................................................ 39 Sloboda and Bukoski SPR Cup ......................................................................................... 42 Wednesday Highlights
    [Show full text]
  • Problems of Drug Dependence 1989: Proceedings of the 51St Annual
    National Institute on Drug Abuse MONOGRAPH SERIES Problems of Drug Dependence 1989 Proceedings of the 51st Annual Scientific Meeting The Committee on Problems of Drug Dependence, Inc. U S DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol, Drug Abuse, and Mental Health Administration Problems of Drug Dependence 1989 Proceedings of the 51st Annual Scientific Meeting The Committee on Problems of Drug Dependence, Inc. Editor: Louis S. Harris, Ph.D. NIDA Research Monograph 95 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICE Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse Off ice of Science 5600 Fishers Lane Rockville, MD 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 NIDA Research Monographs are prepared by the research divisions of the National Institute on Drug Abuse and published by its Office of Science. The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. Its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. MARY L. JACOBSON Temple University School of Medicine National Federation of Parents for Philadelphia, Pennsylvania Drug-free Youth Omaha, Nebraska SYDNEY ARCHER, Ph.D. Rensselaer Polytechnic Institute Troy, New York REESE T. JONES, M.D. Langley Porter Neuropsychiatric Institute RICHARD E. BELLEVILLE, Ph.D. San Francisco, California NB Associates, Health Sciences Rockville, Maryland DENISE KANDEL, Ph.D. KARST J. BESTEMAN College of Physicians and Surgeons of Alcohol and Drug Problems Association Columbia University of North America New York, New York Washington, D.C.
    [Show full text]